TY - JOUR
T1 - International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis from the International Psoriasis Council
AU - Choon, Siew Eng
AU - Van De Kerkhof, Peter
AU - Gudjonsson, Johann E.
AU - De La Cruz, Claudia
AU - Barker, Jonathan
AU - Morita, Akimichi
AU - Romiti, Ricardo
AU - Affandi, Azura Mohd
AU - Asawanonda, Pravit
AU - Burden, Arthur David
AU - Gonzalez, César
AU - Marrakchi, Slaheddine
AU - Mowla, Mohammad Rafiqul
AU - Okubo, Yukari
AU - Oon, Hazel H.
AU - Terui, Tadashi
AU - Tsai, Tsen Fang
AU - Callis-Duffin, Kristina
AU - Fujita, Hideki
AU - Jo, Seong Jin
AU - Merola, Joseph
AU - Mrowietz, Ulrich
AU - Puig, Lluïs
AU - Thaçi, Diamant
AU - Velásquez, Margarita
AU - Augustine, Matthias
AU - El Sayed, Mahira
AU - Navarini, Alexander A.
AU - Pink, Andrew
AU - Prinz, Jörg
AU - Turki, Hamida
AU - Magalhães, Renata
AU - Capon, Francesca
AU - Bachelez, Hervé
N1 - Publisher Copyright:
© 2024 American Medical Association. All rights reserved.
PY - 2024/7/17
Y1 - 2024/7/17
N2 - Importance: Generalized pustular psoriasis (GPP) lacks internationally accepted definitions and diagnostic criteria, impeding timely diagnosis and treatment and hindering cross-regional clinical and epidemiological study comparisons. Objective: To develop an international consensus definition and diagnostic criteria for GPP using the modified Delphi method. Evidence Review: The rarity of GPP presents a challenge in acquiring comprehensive published clinical data necessary for developing standardized definition and criteria. Instead of relying on a literature search, 43 statements that comprehensively addressed the fundamental aspects of the definitions and diagnostic criteria for GPP were formulated based on expert reviews of 64 challenging GPP cases. These statements were presented to a panel of 33 global GPP experts for voting, discussion, and refinements in 2 virtual consensus meetings. Consensus during voting was defined as at least 80% agreement; the definition and diagnostic criteria were accepted by all panelists after voting and in-depth discussion. Findings: In the first and second modified Delphi round, 30 (91%) and 25 (76%) experts participated. In the initial Delphi round, consensus was achieved for 53% of the statements, leading to the approval of 23 statements that were utilized to develop the proposed definitions and diagnostic criteria for GPP. During the second Delphi round, the final definition established was, "Generalized Pustular Psoriasis is a systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules." It can occur with or without systemic symptoms, other psoriasis types, and laboratory abnormalities. GPP may manifest as an acute form with widespread pustules or a subacute variant with an annular phenotype. The identified essential criterion was, "Macroscopically visible sterile pustules on erythematous base and not restricted to the acral region or within psoriatic plaques." Conclusions and Relevance: The achievement of international consensus on the definition and diagnostic criteria for GPP underscores the importance of collaboration, innovative methodology, and expert engagement to address rare diseases. Although further validation is needed, these criteria can serve as a reference point for clinicians, researchers, and patients, which may contribute to more accurate diagnosis and improved management of GPP.
AB - Importance: Generalized pustular psoriasis (GPP) lacks internationally accepted definitions and diagnostic criteria, impeding timely diagnosis and treatment and hindering cross-regional clinical and epidemiological study comparisons. Objective: To develop an international consensus definition and diagnostic criteria for GPP using the modified Delphi method. Evidence Review: The rarity of GPP presents a challenge in acquiring comprehensive published clinical data necessary for developing standardized definition and criteria. Instead of relying on a literature search, 43 statements that comprehensively addressed the fundamental aspects of the definitions and diagnostic criteria for GPP were formulated based on expert reviews of 64 challenging GPP cases. These statements were presented to a panel of 33 global GPP experts for voting, discussion, and refinements in 2 virtual consensus meetings. Consensus during voting was defined as at least 80% agreement; the definition and diagnostic criteria were accepted by all panelists after voting and in-depth discussion. Findings: In the first and second modified Delphi round, 30 (91%) and 25 (76%) experts participated. In the initial Delphi round, consensus was achieved for 53% of the statements, leading to the approval of 23 statements that were utilized to develop the proposed definitions and diagnostic criteria for GPP. During the second Delphi round, the final definition established was, "Generalized Pustular Psoriasis is a systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules." It can occur with or without systemic symptoms, other psoriasis types, and laboratory abnormalities. GPP may manifest as an acute form with widespread pustules or a subacute variant with an annular phenotype. The identified essential criterion was, "Macroscopically visible sterile pustules on erythematous base and not restricted to the acral region or within psoriatic plaques." Conclusions and Relevance: The achievement of international consensus on the definition and diagnostic criteria for GPP underscores the importance of collaboration, innovative methodology, and expert engagement to address rare diseases. Although further validation is needed, these criteria can serve as a reference point for clinicians, researchers, and patients, which may contribute to more accurate diagnosis and improved management of GPP.
UR - http://www.scopus.com/inward/record.url?scp=85192267163&partnerID=8YFLogxK
U2 - 10.1001/jamadermatol.2024.0915
DO - 10.1001/jamadermatol.2024.0915
M3 - Review article
C2 - 38691347
AN - SCOPUS:85192267163
SN - 2168-6068
VL - 160
SP - 758
EP - 768
JO - JAMA dermatology
JF - JAMA dermatology
IS - 7
ER -